Stephen S. Whitehead

Overview

Best Publications

• Prospects for a dengue virus vaccine.

  Stephen S. Whitehead;Joseph E. Blaney;Anna P. Durbin;Brian R. Murphy

  834
  Citations

• The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

  Martina Beltramello;Katherine L. Williams;Cameron P. Simmons;Annalisa Macagno

  707
  Citations

• Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

  Ruth A. Karron;Deborah A. Buonagurio;Alice F. Georgiu;Stephen S. Whitehead

  627
  Citations

• Immune Response to Dengue Virus and Prospects for a Vaccine

  Brian R Murphy;Stephen S Whitehead

  592
  Citations

• Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

  Anna P. Durbin;Ruth A. Karron;Wellington Sun;David W. Vaughn

  450
  Citations

• Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse.

  Alexander Bukreyev;Stephen S. Whitehead;Brian R. Murphy;Peter L. Collins

  390
  Citations

• Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

  Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson

  383
  Citations

• Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.

  Michael N. Teng;Stephen S. Whitehead;Peter L. Collins

  323
  Citations

• Recombinant Respiratory Syncytial Virus Bearing a Deletion of either the NS2 or SH Gene Is Attenuated in Chimpanzees

  Stephen S. Whitehead;Alexander Bukreyev;Michael N. Teng;Cai Yen Firestone

  321
  Citations

• Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees.

  Michael N. Teng;Stephen S. Whitehead;Alison Bermingham;Marisa St. Claire

  298
  Citations

• The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model

  Beth D. Kirkpatrick;Stephen S. Whitehead;Kristen K. Pierce;Cecilia M. Tibery

  260
  Citations

• Dengue viruses cluster antigenically but not as discrete serotypes

  Leah C. Katzelnick;Judith M. Fonville;Judith M. Fonville;Judith M. Fonville;Gregory D. Gromowski;Jose Bustos Arriaga

  249
  Citations

• Maternal antibody and viral factors in the pathogenesis of dengue virus in infants.

  Cameron P. Simmons;Tran Nguyen Bich Chau;Tran Thi Thuy;Nguyen Minh Tuan

  244
  Citations

• Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.

  Joseph E. Blaney;Jennifer M. Matro;Brian R. Murphy;Stephen S. Whitehead

  240
  Citations

• Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

  Beth D. Kirkpatrick;Anna P. Durbin;Kristen K. Pierce;Marya P. Carmolli

  240
  Citations

• Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization

  Steevenson Nelson;Christiane A. Jost;Qinq Xu;Jessica Ess

  239
  Citations

• Recovery of infectious human parainfluenza virus type 3 from cDNA.

  Anna P. Durbin;Susan L. Hall;Jeffrey W. Siew;Stephen S. Whitehead

  235
  Citations

• A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3′ Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys

  Stephen S. Whitehead;Barry Falgout;Kathryn A. Hanley;Joseph E. Blaney

  223
  Citations

• A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.

  Kimberly A. Dowd;Christiane A. Jost;Anna P. Durbin;Stephen S. Whitehead

  203
  Citations

• A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial

  Anna P. Durbin;Beth D. Kirkpatrick;Kristen K. Pierce;Daniel Elwood

  199
  Citations

• The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes

  Daniela Weiskopf;Michael A. Angelo;Derek J. Bangs;John Sidney

  191
  Citations

• A Full-Length Infectious cDNA Clone of Zika Virus from the 2015 Epidemic in Brazil as a Genetic Platform for Studies of Virus-Host Interactions and Vaccine Development

  Konstantin A. Tsetsarkin;Heather Kenney;Rubing Chen;Guangping Liu

  174
  Citations

• Recombinant respiratory syncytial virus (RSV) bearing a set of mutations from cold-passaged RSV is attenuated in chimpanzees.

  Stephen S. Whitehead;Katalin Juhasz;Cai-Yen Firestone;Peter L. Collins

  161
  Citations

• Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation.

  Camilo Ansarah-Sobrinho;Steevenson Nelson;Christiane A. Jost;Stephen S. Whitehead

  159
  Citations

• Genetically modified, live attenuated dengue virus type 3 vaccine candidates.

  Joseph E. Blaney;Christopher T. Hanson;Cai-Yen Firestone;Kathryn A. Hanley

  158
  Citations

• Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?

  Stephen S. Whitehead

  157
  Citations

• Development of a Live Attenuated Dengue Virus Vaccine Using Reverse Genetics

  Joseph E. Blaney;Anna P. Durbin;Brian R. Murphy;Stephen S. Whitehead

  149
  Citations